Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 3, 2022 21:49 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 4,668 | $64.44 | $300,805.92 |
DisclosureSEC source: 0001099219-22-000052 · wf-form4_164634409767047.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,762 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:48 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 780 | $64.44 | $50,263.20 |
DisclosureSEC source: 0001099219-22-000051 · wf-form4_164634406476090.xml · nonDerivative · entry 1 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,166 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:47 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 1,811 | $64.44 | $116,700.84 |
DisclosureSEC source: 0001099219-22-000050 · wf-form4_164634399023405.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,846 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:46 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
Tax withholdingCommon Stock | 2,252 | $64.44 | $145,118.88 |
DisclosureSEC source: 0001099219-22-000049 · wf-form4_164634396522310.xml · nonDerivative · entry 1 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,123 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:46 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 5,437 | $64.44 | $350,360.28 |
DisclosureSEC source: 0001099219-22-000048 · wf-form4_164634394104731.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,770 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:46 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
Tax withholdingCommon Stock | 7,468 | $68.56 | $512,006.08 |
DisclosureSEC source: 0001099219-22-000037 · wf-form4_164617114250507.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,352 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:01 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 29,361 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000034 · wf-form4_164575085774723.xml · derivative · entry 4 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,361 Underlying: Common Stock · 29,361 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:01 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 31,812 | $68.96 | $2,193,755.52 |
DisclosureSEC source: 0001099219-22-000034 · wf-form4_164575085774723.xml · nonDerivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,207 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:01 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 66,457 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000034 · wf-form4_164575085774723.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,019 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:01 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 9,789 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000034 · wf-form4_164575085774723.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,562 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:02 UTC |
Khalaf MichelDirector · President & CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 85,472 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000035 · wf-form4_164575090850543.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,472 Underlying: Common Stock · 85,472 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:02 UTC |
Khalaf MichelDirector · President & CEO
|
Tax withholdingCommon Stock | 108,077 | $68.96 | $7,452,989.92 |
DisclosureSEC source: 0001099219-22-000035 · wf-form4_164575090850543.xml · nonDerivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,804 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:02 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 199,371 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000035 · wf-form4_164575090850543.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,881 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:02 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 28,495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000035 · wf-form4_164575090850543.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,510 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:00 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 28,709 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000033 · wf-form4_164575080290156.xml · derivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,709 Underlying: Common Stock · 28,709 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:00 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 45,324 | $68.96 | $3,125,543.04 |
DisclosureSEC source: 0001099219-22-000033 · wf-form4_164575080290156.xml · nonDerivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,232 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:00 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 88,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000033 · wf-form4_164575080290156.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,556 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 01:00 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 9,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000033 · wf-form4_164575080290156.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,947 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 15,986 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,986 Underlying: Common Stock · 15,986 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 4,098 | $68.96 | $282,598.08 |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,657 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 11,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,755 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 5,330 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000032 · wf-form4_164575076470102.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,442 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantEmployee Stock Options (right to buy) · Derivative | 25,120 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000030 · wf-form4_164575071291393.xml · derivative · entry 2 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,120 Underlying: Common Stock · 25,120 shares Expires 2032-02-21 F2 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantCommon Stock | 8,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000030 · wf-form4_164575071291393.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,820 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 6,416 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000031 · wf-form4_164575074506474.xml · derivative · entry 2 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,416 Underlying: Common Stock · 6,416 shares Expires 2032-02-21 F2 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:59 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantCommon Stock | 2,139 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000031 · wf-form4_164575074506474.xml · nonDerivative · entry 1 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,946 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantEmployee Stock Options (right to buy) · Derivative | 10,864 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000029 · wf-form4_164575068493058.xml · derivative · entry 4 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,864 Underlying: Common Stock · 10,864 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
Tax withholdingCommon Stock | 12,549 | $68.96 | $865,379.04 |
DisclosureSEC source: 0001099219-22-000029 · wf-form4_164575068493058.xml · nonDerivative · entry 3 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,375 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantCommon Stock | 26,582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000029 · wf-form4_164575068493058.xml · nonDerivative · entry 2 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,924 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantCommon Stock | 3,622 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000029 · wf-form4_164575068493058.xml · nonDerivative · entry 1 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,342 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
Ponnavolu KishorePresident, Asia
|
GrantEmployee Stock Options (right to buy) · Derivative | 15,007 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000026 · wf-form4_164575061876163.xml · derivative · entry 4 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,007 Underlying: Common Stock · 15,007 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
Ponnavolu KishorePresident, Asia
|
Tax withholdingCommon Stock | 11,864 | $68.96 | $818,141.44 |
DisclosureSEC source: 0001099219-22-000026 · wf-form4_164575061876163.xml · nonDerivative · entry 3 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,820 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
Ponnavolu KishorePresident, Asia
|
GrantCommon Stock | 26,582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000026 · wf-form4_164575061876163.xml · nonDerivative · entry 2 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,684 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
Ponnavolu KishorePresident, Asia
|
GrantCommon Stock | 5,003 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000026 · wf-form4_164575061876163.xml · nonDerivative · entry 1 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,102 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 10,766 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,766 Underlying: Common Stock · 10,766 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 11,438 | $68.96 | $788,764.48 |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,249 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 26,582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,687 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 3,590 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,105 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantEmployee Stock Options (right to buy) · Derivative | 25,283 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000027 · wf-form4_164575063907117.xml · derivative · entry 4 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,283 Underlying: Common Stock · 25,283 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 22,322 | $68.96 | $1,539,325.12 |
DisclosureSEC source: 0001099219-22-000027 · wf-form4_164575063907117.xml · nonDerivative · entry 3 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,430 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 44,304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000027 · wf-form4_164575063907117.xml · nonDerivative · entry 2 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,752 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:57 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 8,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000027 · wf-form4_164575063907117.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,448 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 21:48 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 78,691 | $0.00 Strike: $34.21 | $0.00 |
DisclosureSEC source: 0001099219-22-000008 · wf-form4_164452968662328.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,691 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 8,391 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 28, 2013, 2014 and 2015. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 21:48 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 56,857 | $70.29 | $3,996,376.19 |
DisclosureSEC source: 0001099219-22-000008 · wf-form4_164452968662328.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,376 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 8, 2022 and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $70.25 to $70.42, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 21:48 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 78,691 | $34.21 | $2,692,019.11 |
DisclosureSEC source: 0001099219-22-000008 · wf-form4_164452968662328.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:44 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000022 · wf-form4_164141901487455.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,314 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:43 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000021 · wf-form4_164141898217086.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,688 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:42 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000020 · wf-form4_164141895667153.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,224 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:42 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 1,088 | $63.23 | $68,794.24 |
DisclosureSEC source: 0000937834-22-000019 · wf-form4_164141892454031.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,863 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees and 50% of Board Chair retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:42 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000018 · wf-form4_164141887252353.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,260 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.